Fig. 2From: Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN)Proportion of responses including each factor influencing initiation of thromboprophylaxis in patients with Cushing’s syndrome (not mutually exclusive). BG blood group, CD Cushing’s disease, CS Cushing’s syndrome, VTE venous thromboembolism, vWF von Willebrand FactorBack to article page